BGI Genomics
300676----
Q3 2026 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: BGI Genomics(300676) the Revenue is 904.49 M (-13.24%);the EBIT is 33.51 M (+210.1%);the EPS is 0.007 (+110.8%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.90B13.24%
----
----
EBIT
0.03B210.14%
----
----
EPS
0.007110.75%
----
----
Upcoming earnings report - Annual FY2026
Available dateApr 30, 2027
Estimate Revenue¥3.962 B
Estimate EBIT¥119.26 M
Estimate EPS¥0.27
Revenue
ActualEstimateUnit: CNY
Quarterly
EBIT
ActualEstimateUnit: CNY
Quarterly
Net income
ActualEstimateUnit: CNY
Quarterly
EPS
ActualEstimateUnit: CNY
Quarterly